Quality assurance target for community-based breast cancer screening in China: a model simulation

BMC Cancer

Table 3 The cost-utility analysis of different screening strategy

Screening Strategy	Utility (QALY)	Cost (million USD)	ICUR^a (USD/QALY)	ICUR^b (USD/QALY)	CU (USD/QALY)
No screen	2388 195	96.08	–	–	40.23
1/3 years	2388 782	100.23	7075.77	7075.77	41.96
1/2 years	2389 034	102.28	7394.60	8137.29	42.81
1/1 year	2389 778	108.27	7701.68	8047.96	45.30

Abbreviations: CU Cost/Utility, ICUR incremental cost-utility ratio, QALY quality-adjusted life-year
ICUR ^a based on the no screen strategy; ICUR ^b based on the previous screening strategy

ISSN: 1471-2407